Dr. Benjamin Dwight Renelus, MD

Dr. Renelus practices at Wellstar Medical Group in Douglasville, Georgia.

Dr. Renelus' NPI, 1760827331, was assigned on May 8, 2013. Dr. Renelus graduated from Morehouse School of Medicine in 2012. Dr. Renelus holds Georgia license 76667.

Dr. Renelus' primary practice is Wellstar Medical Group, at 8901 Stonebridge Blvd, Douglasville, GA 30134 in Douglas County. The practice phone is (470) 267-2433.

Dr. Renelus' primary practice is Wellstar Medical Group in Douglasville, Georgia. Dr. Renelus is also affiliated with Wellstar Douglas Medical Center. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. Renelus to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renelus practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Renelus' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Renelus' licenses on file in 2 states: Georgia and Maryland.

CMS data shows 206 Medicare services from Dr. Renelus across 6 procedure codes in 2024, for 147 Medicare patients. Medicare paid $25,168 for them.

CMS counts 147 Medicare patients who saw Dr. Renelus in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Renelus' median patient age at 58, with 63% women.

In 2024, Dr. Renelus wrote 383 Medicare Part D claims for 219 patients. 74% of them were for generic drugs. CMS names the drug for 282 of them, across 10 drugs with 11 or more claims each, at $17,349 in total drug cost. In 2023, CMS named 263 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Renelus for performance year 2024, reported through an alternative payment model (APM). Dr. Renelus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 63 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Renelus, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 17 papers to Dr. Renelus, published from 2016 to 2023. 2020 was the busiest year, with 5. The most frequent topics are Black or African American, COVID-19 and Morbidity. Dr. Renelus has published most often in Ann Gastroenterol. Dr. Renelus' most frequent co-authors are Daniel Sabido Jamorabo, MD, Ezana Negussu Bekele and Jonathan Michael Buscaglia, MD.

CMS Open Payments shows 153 general payments to Dr. Renelus from 22 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Phathom Pharmaceuticals, Inc. paid the most, $2,414.

Dr. Renelus graduated from Morehouse School of Medicine in 2012.